Roll-up of 2 projects. Projects are the summable leaves — the PE total is their sum, never added to it.
For fiscal year 2027, the U.S. Army is requesting $15.0M for Biotechnology for Materials - Applied Research under RDT&E program element 0602386A, up 82% over FY2026.
Funding profile, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 10.5 |
| FY2026 | Enacted | 8.2 |
| FY2027 | Request | 15.0 |
| FY2028 | Outyear | 18.6 |
| FY2029 | Outyear | 18.8 |
| FY2030 | Outyear | 19.0 |
| FY2031 | Outyear | 19.2 |
Acquisition lifecycle
This program is funded in RDT&E Budget Activity 2 — Applied Research.
2 projects roll up into PE 0602386A
Projects are the summable leaves — the PE total is their sum, never added to it. Program elements and projects carry the full five-year plan; activities stop at the budget year. This PE moves 82% overall, which can hide much larger swings below.
Scale-Up Microbial Products for Biomanufacturing
Congressional marks
Committee marks on the FY2027 request. Adds and cuts are reconciled in conference before they become law.
Mission & acquisition strategy
This PE investigates, designs, and performs research focused on novel biotechnological methods, techniques, and materials to increase the resiliency of the military supply chain. The Army is responsible for centrally managing funding for Tri-Service Biotechnology for a Resilient Supply Chain (T-BRSC) efforts. T-BRSC leverages bio-industrial manufacturing to ensure critical domestic supply chain resilience for defense needs through domestic production of raw materials and critical products. Efforts under this PE collaborate with sister Services and select allied partners to create a cohesive biotechnology architecture to enable defense needs.
Ask this program element
Answers are generated from the figures on this page — the FY2027 justification exhibits and the marks tracked above — and nothing else is consulted. Confirm any figure against the cited exhibit before you use it externally.
This page carries the budget justification and the NDAA marks — nothing else. For what a contractor has actually been obligated, the ledger is at hitchintel.com/vendors; for live solicitations, hitchintel.com/opportunities. Both are member surfaces.
Cite this page
/programs/0602386A.md · MCP mcp.hitchintel.com → budget_get_program_element, budget_get_cong_marksFoundational Biotechnology Design and Dev — one RDT&E project inside PE 0602386A. Congressional marks are recorded on the program element, not on a project.
Project CP6 — Foundational Biotechnology Design and Dev — requests $15.0M in FY2027, 100% of the $15.0M requested for program element 0602386A. Year over year it grows 108% against FY2026.
Project CP6 funding, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 9.6 |
| FY2026 | Enacted | 7.2 |
| FY2027 | Request | 15.0 |
| FY2028 | Outyear | 18.6 |
| FY2029 | Outyear | 18.8 |
| FY2030 | Outyear | 19.0 |
| FY2031 | Outyear | 19.2 |
2 accomplishments / planned programs
The R-2A exhibit. Activities carry the prior, current and budget year only — no five-year plan — and they are descriptive: coverage is partial and they do not always add back to the project, so count them, never total them. Opening lines only here — the full year-by-year narrative is on the project page.
Will continue collaboratively with Joint Service partners to research, develop, exploit, and integrate biotechnologies to secure the supply chain of military materials for munitions, energetics, fuels, lubricants, fabrics, ceramics, and composites to enhance the capability of DoW systems performance. Chartered to create a pipeline…
Will use synthetic biology to design and develop protective materials and/or additives across the electro-optical/electromagnetic (EO/EM) spectrum; investigate biomaterial integration into polymers and composites; investigate the use of synthetic biology to engineer microorganisms for multi-stimuli input sensing and situational awareness…
What project CP6 buys
This project works collaboratively with Joint Service partners to investigate and determine novel biotechnology methods and processes to establish a domestic resilient supply chain for defense needs. Applied research designs and conducts experiments on bio-derived, bio-functionalized, and bio-manufactured materials and biosynthetic precursors. Efforts under this project investigate and validate models for design of defense applications. Areas of focus may include reclamation or sequestration of rare Earth/critical elements in the defense supply chain and drop-in replacements for currently employed military materials. This project develops biomanufacturing capabilities of mission-critical materials for military use. This project enables the Army to achieve Multi-Domain Operations by securing the supply chain and bridging the gap between laboratory-scale material production and large-scale manufacturing for mission-critical materials. This project also designs and investigates materials through the application of biotechnology and synthetic biology advances to develop material capabilities that respond and/or can adapt to a wide range of external stimuli and biological processes. Research into innovative materials that are capable of sensing, responding, and adapting to a broad spectrum of environmental variables will be conducted. Efforts will also focus on developing models, materials characterization techniques, non-destructive testing methods, advanced fabrication and processing methodologies, and the identification of unique material properties. Work in this project compliments PE 0603386A (Biotechnology for Materials - Advanced Research) / CP7 (Biotechnology Demonstration and Evaluation).
Scale-Up Microbial Products for Biomanufacturing — one RDT&E project inside PE 0602386A. Congressional marks are recorded on the program element, not on a project.
Project SM1 — Scale-Up Microbial Products for Biomanufacturing — requests — in FY2027, 0.0% of the $15.0M requested for program element 0602386A. Year over year it falls 100% against FY2026.
Project SM1 funding, FY2025–FY2026
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 0.9 |
| FY2026 | Enacted | 1.0 |
1 accomplishment / planned program
The R-2A exhibit. Activities carry the prior, current and budget year only — no five-year plan — and they are descriptive: coverage is partial and they do not always add back to the project, so count them, never total them.
FY2026 to FY2027 change Funding decrease reflects support the creation of Foundational Biotechnology in FY 2027
FY2026 plans — current year Will continue to develop and deliver 100-gram to multi-kilogram purified materials via biomanufacturing that will be ready for incorporation into existing prototypes and programs either as drop-in replacements or new solutions.
FY2025 accomplishments Will develop and deliver 100-gram to multi-kilogram purified materials via biomanufacturing that will be ready for incorporation into existing prototypes and programs either as drop-in replacements or new solutions.
What project SM1 buys
This project develops biomanufacturing capabilities of mission-critical materials for military use. This project enables the Army to achieve Multi-Domain Operations by securing the supply chain and bridging the gap between laboratory-scale material production and large-scale manufacturing for mission-critical materials. Work in this project is performed by the Chemical Biological Center (CBC). The project SM1/Scale-Up Microbial Products for Biomanufacturing is a new start in FY 2025 within PE 0602386A / Biotechnology for Materials - Applied Research.